MTUM vs VHT
iShares MSCI USA Momentum Factor ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.15% for MTUM.
- • VHT pays a higher dividend yield (1.58%).
Side-by-side metrics
| Metric | MTUM | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.54% | 1.58% |
AUM Assets under management — bigger funds are typically more liquid. | $29.05B | $20.39B |
YTD return | 26.03% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.24 | 0.57 |
P/E ratio | 33.08 | 26.46 |
Last price | $321.20 | $306.54 |
Inception | — | — |
Issuer | iShares | Vanguard |
MTUM top holdings
| MU | Micron Technology Inc | 7.19% |
| INTC | Intel Corp | 5.49% |
| AMD | Advanced Micro Devices Inc | 5.44% |
| CAT | Caterpillar Inc | 4.17% |
| AVGO | Broadcom Inc | 4.00% |
| LRCX | Lam Research Corp | 4.00% |
| AMAT | Applied Materials Inc | 3.86% |
| GEV | GE Vernova Inc | 3.18% |
| JNJ | Johnson & Johnson | 3.06% |
| XOM | Exxon Mobil Corp | 2.89% |
VHT top holdings
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
About MTUM
MTUM (iShares MSCI USA Momentum Factor ETF) is US large-caps with momentum tilt. Managed by iShares, the fund carries $29.0B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.54%. Its largest holding is Micron Technology Inc (MU), which represents 7.2% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.